Figure 16.
(A) Histopathological alterations are affected (10×) by RZ-NLCs and RZ-NLCsG. Normal architecture is seen in the vehicle-treated group, but myonecrosis, inflammation, and edema are seen in the vasopressin-control group. When compared to those treated with the RZ-NLCsG group, it exhibits considerable skin protection by reducing myonecrosis, edema, and inflammation. (B) Severity score for blinded histological evaluation in comparison to RZ-NLCsG-treated group. Values are expressed in mean ± SD, n = 3 * p > 0.05, ** p > 0.02, *** p > 0.001.